Latest news
New Updates in Drug Formulation and Bioavailability
Iconovo´s CEO Dr Orest Lastow will be moderating the New Updates in Drug Formulation and Bioavailability conference in Copenhagen 7 April. Formulation…
Computational Fluid Dynamics, CFD
Iconovo has invested in the Autodesk Simulation CFD software. Iconovo CEO Dr Orest Lastow was previously head of the AstraZeneca CFD group and has long…
Press releases
Feb 12, 2026, 08:30
News
IR
English
Regulatory
MAR
Report
Interim
Yearend
Feb 12, 2026, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Yearend
Jan 15, 2026, 10:15
News
IR
English
Corporate Action
Other
mfn-ext-nq
mfn-ext-nq-corporate-action
Jan 15, 2026, 10:15
News
IR
Swedish
Corporate Action
Other
mfn-ext-nq
mfn-ext-nq-corporate-action
Jan 13, 2026, 13:40
News
IR
English
Corporate Action
Other
mfn-ext-nq
mfn-ext-nq-corporate-action
Jan 13, 2026, 13:40
News
IR
Swedish
Corporate Action
Other
mfn-ext-nq
mfn-ext-nq-corporate-action
Dec 22, 2025, 10:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-listing
Dec 22, 2025, 10:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-listing
Dec 16, 2025, 12:45
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Other
mfn-cus-disclaimer
mfn-cus-top-disclaimer
mfn-ext-nq
mfn-ext-nq-corporate-action
Dec 16, 2025, 12:45
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Action
Other
mfn-cus-disclaimer
mfn-cus-top-disclaimer
mfn-ext-nq
mfn-ext-nq-corporate-action
Dec 15, 2025, 10:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
Nov 25, 2025, 21:15
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Nov 25, 2025, 21:05
News
IR
Swedish
Regulatory
MAR
Corporate Action
Other
mfn-cus-top-disclaimer
mfn-ext-nq
mfn-ext-nq-corporate-action
Nov 25, 2025, 21:05
News
IR
English
Regulatory
MAR
Corporate Action
Other
mfn-cus-top-disclaimer
mfn-ext-nq
mfn-ext-nq-corporate-action
Oct 31, 2025, 09:35
News
IR
English
Regulatory
MAR
Corporate Information
Staff change
Oct 14, 2025, 15:37
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-inside-information
Oct 14, 2025, 15:37
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-inside-information
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
CEO
Anders Månsson
Mail: anders.mansson@iconovo.se
Press releases
Follow us on Linkedin
